ELAPEGADEMASE-LVLR: 257 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
257
Total FAERS Reports
3 (1.2%)
Deaths Reported
37
Hospitalizations
257
As Primary/Secondary Suspect
Prescription
Status
FDA Application: 761092 ·
First Report: 20170906 · Latest Report: 20250815
What Are the Most Common ELAPEGADEMASE-LVLR Side Effects?
#1 Most Reported
Nasopharyngitis
29 reports (11.3%)
#2 Most Reported
Covid-19
21 reports (8.2%)
#3 Most Reported
Cough
20 reports (7.8%)
All ELAPEGADEMASE-LVLR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Nasopharyngitis | 29 | 11.3% | 0 | 0 |
| Covid-19 | 21 | 8.2% | 0 | 2 |
| Cough | 20 | 7.8% | 0 | 1 |
| Bone marrow transplant | 13 | 5.1% | 0 | 4 |
| Sinusitis | 12 | 4.7% | 0 | 1 |
| Weight decreased | 12 | 4.7% | 0 | 2 |
| Pyrexia | 10 | 3.9% | 0 | 4 |
| Injection site pain | 9 | 3.5% | 0 | 0 |
| Pneumonia | 9 | 3.5% | 1 | 7 |
| Product dose omission | 8 | 3.1% | 0 | 0 |
| Rhinorrhoea | 8 | 3.1% | 0 | 0 |
| Rash | 7 | 2.7% | 0 | 1 |
| Weight increased | 7 | 2.7% | 0 | 0 |
| Diarrhoea | 6 | 2.3% | 0 | 0 |
| Headache | 6 | 2.3% | 0 | 1 |
| Off label use | 6 | 2.3% | 0 | 2 |
| Gastroenteritis viral | 5 | 2.0% | 0 | 1 |
| Infection | 5 | 2.0% | 1 | 1 |
| Viral infection | 5 | 2.0% | 0 | 0 |
Who Reports ELAPEGADEMASE-LVLR Side Effects? Age & Gender Data
Gender: 50.2% female, 49.8% male. Average age: 17.1 years. Most reports from: US. View detailed demographics →
Is ELAPEGADEMASE-LVLR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 0 |
| 2019 | 16 | 0 | 4 |
| 2020 | 10 | 0 | 0 |
| 2021 | 27 | 2 | 5 |
| 2022 | 59 | 0 | 7 |
| 2023 | 38 | 0 | 8 |
| 2024 | 33 | 0 | 6 |
| 2025 | 2 | 1 | 2 |
What Is ELAPEGADEMASE-LVLR Used For?
| Indication | Reports |
|---|---|
| Combined immunodeficiency | 242 |
| Product used for unknown indication | 7 |
| Immunodeficiency | 5 |
ELAPEGADEMASE-LVLR vs Alternatives: Which Is Safer?
ELAPEGADEMASE-LVLR vs ELASOMERAN
ELAPEGADEMASE-LVLR vs ELBASVIR
ELAPEGADEMASE-LVLR vs ELBASVIR\GRAZOPREVIR
ELAPEGADEMASE-LVLR vs ELDECALCITOL
ELAPEGADEMASE-LVLR vs ELECTROLYTES NOS
ELAPEGADEMASE-LVLR vs ELECTROLYTES NOS\MINERALS
ELAPEGADEMASE-LVLR vs ELETRIPTAN
ELAPEGADEMASE-LVLR vs ELETRIPTAN HYDROBROMIDE
ELAPEGADEMASE-LVLR vs ELEXACAFTOR\IVACAFTOR\TEZACAFTOR
ELAPEGADEMASE-LVLR vs ELIGLUSTAT
Official FDA Label for ELAPEGADEMASE-LVLR
Official prescribing information from the FDA-approved drug label.